Pillar Biosciences Names Pritchard as Chief Executive Officer
2 September 2021 - - US- and China-based in-vitro diagnostics company Pillar Biosciences has appointed Randy Pritchard as chief executive officer, the company said.

The company's founder, industry veteran and renowned scientific innovator, Gang Song, Ph.D., will transition to the role of chairman of the board, where he will be responsible for leading the board, ensuring governance standard and focusing on all strategic matters for Pillar Biosciences.

In his new role as CEO, Pritchard will look to accelerate the company's efforts to make precision oncology accessible for all patients throughout the patient journey.

Pritchard brings to Pillar Biosciences more than 24 years of healthcare experience, as a diagnostics executive who has deep experience in corporate and commercial strategy, sales and marketing, driving growth through innovation.

He has held positions of increasing responsibilities, including SVP of US Diagnostics marketing, SVP and Lifecycle Leader at the divisions of POC Diagnostic and Core Reagents, and VP of Marketing at Centralized Diagnostics at Roche Diagnostics.

Pillar Biosciences is a global oncology solutions company delivering in-vitro diagnostics that provide accurate, robust, timely, clinically actionable insights to guide treatment decisions throughout a patient's continuum of care.

Pillar has operations in Natick, MA and Shanghai, China.